{"abstract": "The new drug, the company\u2019s best hope for future growth, won a partial endorsement from a federal advisory committee despite concerns about the product\u2019s safety.", "web_url": "https://www.nytimes.com/2009/08/14/business/14bone.html", "snippet": "The new drug, the company\u2019s best hope for future growth, won a partial endorsement from a federal advisory committee despite concerns about the product\u2019s safety.", "lead_paragraph": "Amgen\u2019s new bone drug, the company\u2019s best hope for future growth, won a partial endorsement Thursday from a federal advisory committee despite concerns about the product\u2019s safety. ", "print_section": "B", "print_page": "2", "source": "The New York Times", "multimedia": [], "headline": {"main": "A Partial Approval for Amgen\u2019s Osteoporosis Drug", "kicker": null, "content_kicker": null, "print_headline": "A Partial Approval for Amgen\u2019s Osteoporosis Drug", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 1, "major": "N"}, {"name": "subject", "value": "Bones", "rank": 2, "major": "N"}, {"name": "organizations", "value": "Food and Drug Administration", "rank": 3, "major": "N"}, {"name": "organizations", "value": "AMGEN INC", "rank": 4, "major": "N"}], "pub_date": "2009-08-14T01:13:41+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Andrew Pollack", "person": [{"firstname": "Andrew", "middlename": null, "lastname": "Pollack", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/c5a099bd-c657-5732-b260-db9eddf9aeb4", "word_count": 751, "uri": "nyt://article/c5a099bd-c657-5732-b260-db9eddf9aeb4"}